Free shipping on all orders over $ 500

Ponalrestat

Cat. No. M9725
Ponalrestat Structure
Synonym:

MK-538; Statil

Size Price Availability Quantity
10mg USD 50  USD50 In stock
50mg USD 105  USD105 In stock
100mg USD 180  USD180 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ponalrestat is an orally active, selective and noncompetitive aldose reductase inhibitor. Ponalrestat selectively inhibits ALR2 (Ki=7.7 nM) over ALR1 (Ki=60 μM). Ponalrestat activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice. Ponalrestat is effective in the attenuation of the cachectic symptoms induced by human melanomas G361 and SEKI in nude mice.

Chemical Information
Molecular Weight 391.19
Formula C17H12BrFN2O3
CAS Number 72702-95-5
Form Solid
Solubility (25°C) DMSO ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Eva Bresson, et al. J Clin Endocrinol Metab. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium

[2] N A Calcutt, et al. Diabetologia. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor

[3] W H Ward, et al. Biochem Pharmacol. Ponalrestat: a potent and specific inhibitor of aldose reductase

Related Aldose Reductase Products
AKR1C3-IN-10

AKR1C3-IN-10 is a selective AKR1C3 inhibitor (IC50=51 nM).

Dehydroglyasperin D

Dehydroglyasperin D inhibits rat and human Aldose Reductase (AR) (IC50: 62.4 μM and 176.2 μM respectively).

Ganoderic acid Df

Ganoderic acid Df is a lanostane-type triterpenoid, that can be isolated from the fruiting body of Ganoderma lucidum.

Danshenol A

Danshenol A is an aldose reductase (AR) inhibitor with an IC50 of 0.1 μM. Danshenol A can protect endothelial cells from oxidative stress by directly scavenging ROS. Danshenol A has anti-inflammatory and antitumor properties.

Hydroxyevodiamine

Hydroxyevodiamine (Rhetsinine) inhibits aldose reductase with an IC50 value of 24.1 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ponalrestat, MK-538; Statil supplier, Aldose Reductase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.